Role of RBM25/LUC7L3 in abnormal cardiac sodium channel splicing regulation in human heart failure

Circulation

Volumn 124, Issue 10, 2011, Pages 1124-1131

  Gao, Ge ^a   Xie, An ^a   Huang, Shu Ching ^b   Zhou, Anyu ^b   Zhang, Jianhua ^c   Herman, Amanda M ^c   Ghassemzadeh, Sassan ^d   Jeong, Euy Myoung ^a   Kasturirangan, Srinivasan ^a   Raicu, Mihai ^a   Sobieski, Michael A ^e   Bhat, Geetha ^e   Tatooles, Antone ^e   Benz, Edward J ^b   Kamp, Timothy J ^c   Dudley, Samuel C ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

^e ADVOCATE CHRIST MEDICAL CENTER   (United States)

Author keywords

angiotensin II; arrhythmia; cardiomyopathy; gene expression; sodium

Indexed keywords

LUC7L3 PROTEIN; MESSENGER RNA; NUCLEAR PROTEIN; RBM25 PROTEIN; RNA BINDING PROTEIN; SODIUM CHANNEL NAV1.5; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HEART DEATH; HEART FAILURE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL LINE; PRIORITY JOURNAL; RNA SPLICING; SPLICEOSOME; SUDDEN DEATH;

ADULT; AGED; CELLS, CULTURED; DOWN-REGULATION; EMBRYONIC STEM CELLS; FEMALE; GENE EXPRESSION PROFILING; HEART FAILURE; HUMANS; JURKAT CELLS; MALE; MIDDLE AGED; MYOCYTES, CARDIAC; RNA SPLICING; RNA-BINDING PROTEINS; SODIUM CHANNELS; SPLICEOSOMES; UP-REGULATION; YOUNG ADULT;

EID: 80052604415     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.044495     Document Type: Article

References (31)

1. Modrek B, Lee C. A genomic view of alternative splicing. Nat Genet. 2002;30:13-19.
2. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. 2008;40:1413-1415.
3. Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010;10: 389-402.
4. Du H, Cline MS, Osborne RJ, Tuttle DL, Clark TA, Donohue JP, Hall MP, Shiue L, Swanson MS, Thornton CA, Ares M Jr. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat Struct Mol Biol. 2010;17:187-193.
5. Novak AJ, Slager SL, Fredericksen ZS, Wang AH, Manske MM, Ziesmer S, Liebow M, Macon WR, Dillon SR, Witzig TE, Cerhan JR, Ansell SM. Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma. Cancer Res. 2009;69:4217-4224.
6. Reyal F, van Vliet MH, Armstrong NJ, Horlings HM, de Visser KE, Kok M, Teschendorff AE, Mook S, van 't Veer L, Caldas C, Salmon RJ, van de Vijver MJ, Wessels LF. A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer. Breast Cancer Res. 2008;10:R93.
7. Licatalosi DD, Darnell RB. RNA processing and its regulation: global insights into biological networks. Nat Rev Genet. 2010;11:75-87.
8. Shang LL, Pfahnl AE, Sanyal S, Jiao Z, Allen J, Banach K, Fahrenbach J, Weiss D, Taylor WR, Zafari AM, Dudley SC Jr. Human heart failure is associated with abnormal C-terminal splicing variants in the cardiac sodium channel. Circ Res. 2007;101:1146-1154. (Pubitemid 350146441)
9. Bartoszewski R, Rab A, Jurkuvenaite A, Mazur M, Wakefield J, Collawn JF, Bebok Z. Activation of the unfolded protein response by OF508 CFTR. Am J Respir Cell Mol Biol. 2008;39:448-457.
10. Keller SH, Platoshyn O, Yuan JX. Long QT syndrome-associated I593R mutation in HERG potassium channel activates ER stress pathways. Cell Biochem Biophys. 2005;43:365-377. (Pubitemid 41506876)
11. Shibata EF, Brown TL, Washburn ZW, Bai J, Revak TJ, Butters CA. Autonomic regulation of voltage-gated cardiac ion channels. J Car-diovasc Electrophysiol. 2006;17(suppl 1):S34-S42.
12. Zhou A, Ou AC, Cho A, Benz EJ Jr, Huang SC. Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5' splice site selection. Mol Cell Biol. 2008;28:5924-5936.
13. Puig O, Bragado-Nilsson E, Koski T, Seraphin B. The U1 snRNP-associated factor Luc7p affects 5' splice site selection in yeast and human. Nucleic Acids Res. 2007;35:5874-5885. (Pubitemid 47506302)
14. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res. 2009;104:e30-e41.
15. + current regulation by pyridine nucleotides. Circ Res. 2009;105:737-745.
16. Stearman RS, Dwyer-Nield L, Zerbe L, Blaine SA, Chan Z, Bunn PA, Jr., Johnson GL, Hirsch FR, Merrick DT, Franklin WA, Baron AE, Keith RL, Nemenoff RA, Malkinson AM, Geraci MW. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am J Pathol. 2005;167:1763-1775. (Pubitemid 41713326)
17. Ricco R, Kanduc D. Hepatitis B virus and Homo sapiens proteome-wide analysis: a profusion of viral peptide overlaps in neuron-specific human proteins. Biologics. 2010;4:75-81.
18. Inuzuka Y, Okuda J, Kawashima T, Kato T, Niizuma S, Tamaki Y, Iwanaga Y, Yoshida Y, Kosugi R, Watanabe-Maeda K, Machida Y, Tsuji S, Aburatani H, Izumi T, Kita T, Shioi T. Suppression of phosphoinosi-tide 3-kinase prevents cardiac aging in mice. Circulation. 2009;120: 1695-1703.
19. Claus EB, Park PJ, Carroll R, Chan J, Black PM. Specific genes expressed in association with progesterone receptors in meningioma. Cancer Res. 2008;68:314-322. (Pubitemid 351380134)
20. Li YL, Xia XH, Zheng H, Gao L, Li YF, Liu D, Patel KP, Wang W, Schultz HD. Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits. Cardiovasc Res. 2006;71:129-138. (Pubitemid 43849673)
21. + channel activity. FEBS Lett. 2004;569:191-194. (Pubitemid 38844616)
22. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237. (Pubitemid 40110811)
23. Wahl MC, Will CL, Luhrmann R. The spliceosome: design principles of a dynamic RNP machine. Cell. 2009;136:701-718.
24. Shang LL, Dudley SC Jr. Tandem promoters and developmentally regulated 5'-and 3'-mRNA untranslated regions of the mouse Scn5a cardiac sodium channel. J Biol Chem. 2005;280:933-940.
25. Choudhary G, Dudley SC Jr. Heart failure, oxidative stress, and ion channel modulation. Congest Heart Fail. 2002;8:148-155. (Pubitemid 34665625)
26. Moro C, Hernandez-Madrid A, Matia R. Non-antiarrhythmic drugs to prevent atrial fibrillation. Am J Cardiovasc Drugs. 2010;10:165-173.
27. Gao G, Dudley SC Jr. Redox regulation, NF-κB, and atrial fibrillation. Antioxid Redox Signal. 2009;11:2265-2277.
28. Nishii Y, Morishima M, Kakehi Y, Umehara K, Kioka N, Terano Y, Amachi T, Ueda K. CROP/Luc7A, a novel serine/arginine-rich nuclear protein, isolated from cisplatin-resistant cell line. FEBS Lett. 2000;465: 153-156. (Pubitemid 30021464)
29. De CR, Ruigomez A, Rodriguez LA. Long-term use of anti-inflammatory drugs and risk of atrial fibrillation. Arch Intern Med. 2010;170: 1450-1455.
30. Hutchinson KR, Stewart JA Jr, Lucchesi PA. Extracellular matrix remodeling during the progression of volume overload-induced heart failure. J Mol Cell Cardiol. 2010;48:564-569.
31. Burashnikov A, Antzelevitch C. Atrial-selective sodium channel block for the treatment of atrial fibrillation. Expert Opin Emerg Drugs. 2009;14:233-249.